drugset / Trial / NCT02712957
A Proof-of-Concept Study Assessing NEO6860 in Osteoarthritis Pain
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this study is to assess NEO6860, a modality selective TRPV1 antagonist, in patients with pain associated with osteoarthritis of the knee.
Timeline
- Start
- 2016-03
- Primary completion
- 2016-11-17
- Completion
- 2016-11-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NEO6860 | Small molecule | 500 mg | Oral |
| Comparator | Naproxen | Small molecule | 500 mg | Oral |